RRPV Solicitation Summary: NextGen Oral Formulation Vaccines for COVID-19
| Location: | District of Columbia |
|---|---|
| Posted: | Oct 1, 2024 |
| Due: | Nov 1, 2024 |
| Agency: | HEALTH AND HUMAN SERVICES, DEPARTMENT OF |
| Type of Government: | Federal |
| Category: |
|
| Solicitation No: | RRPV-24-02-OralVx |
| Publication URL: | To access bid details, please log in. |
- Contract Opportunity Type: Special Notice (Updated)
- Updated Published Date: Oct 01, 2024 03:02 pm EDT
- Original Published Date: Sep 10, 2024 07:04 am EDT
- Updated Response Date: Nov 01, 2024 01:00 pm EDT
- Original Response Date: Oct 18, 2024 01:00 pm EDT
- Inactive Policy: 15 days after response date
- Updated Inactive Date: Nov 16, 2024
- Original Inactive Date: Nov 02, 2024
-
Initiative:
- None
- Original Set Aside:
- Product Service Code: AN42 - HEALTH R&D SERVICES; HEALTH CARE - OTHER; APPLIED RESEARCH
-
NAICS Code:
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
-
Place of Performance:
DCUSA
This solicitation summary is to notify all potential offerors of a Request for Project Proposals (RPP) issued through the Rapid Response Partnership Vehicle (RRPV) Consortium on behalf of the Biomedical Advanced Research and Development Authority (BARDA) titled, "NextGen Oral Formulation Vaccines for COVID-19". The purpose of this effort is to advance oral vaccine platforms and technologies into a proof-of-concept Phase 1 clinical trial, improve our understanding of their potential, and to provide better COVID-19 solutions and bolster preparedness and response against future health security threats. The full RPP and information on joining the consortium can be accessed through the RRPV website at www.rrpv.org.
Amended to extend the due date from 18 October 2024 to 1 November 2024.
- O’NEILL HOUSE OFFICE BUILDING
- WASHINGTON , DC 20515
- USA
- Rebecca Harmon
- rebecca.harmon@ati.org
Related Document
| Sep 10, 2024 | [Special Notice (Original)] RRPV Solicitation Summary: NextGen Oral Formulation Vaccines for COVID-19 |
| Oct 29, 2024 | [Special Notice (Updated)] RRPV Solicitation Summary: NextGen Oral Formulation Vaccines for COVID-19 |
With GovernmentContracts, you can:
- Find more opportunities and win more business
- Receive daily alerts for all new bid opportunities
- Get contract opportunities matched to your business
See also
Follow Hearing Enhancement through ARtificially Intelligent NeurotechnoloGy (HEARING) Active Contract Opportunity Notice ID
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Bid Due: 8/14/2026
Follow GPO G-Street Sidewalk Repair Active Contract Opportunity Notice ID 040ADV-26-R-0010 Related Notice
UNITED STATES GOVERNMENT PUBLISHING OFFICE
Bid Due: 7/06/2026
Project ID: Title: Organics Collection and Disposal Services Addenda: 5 Release Date: 3/5/2026
District of Columbia
Bid Due: 6/16/2026
Follow NAVAL RESEARCH LABORATORY (NRL) FACILITY SUPPORT SERVICES (FSS) Active Contract Opportunity Notice
DEPT OF DEFENSE
Bid Due: 6/19/2026